A new Metabolic Multimorbidity Burden Index highlights marked differences in self-rated health among US adults. Read more.
THE ALZHEIMER’S Association announced at AAIC 2026 the launch of PROTECT-Cog, a new global trial testing whether combining ...
Enlicitide receives FDA approval as the first oral PCSK9 inhibitor, offering a new approach to lowering cholesterol in adults ...
Perineural invasion may help refine risk assessment in intrahepatic bile duct cancer. Find out what this meta-analysis means ...
Is Testosterone Replacement Therapy safe during active surveillance for prostate cancer? Read about the latest clinical ...
LOW serum zinc level was independently associated with poor renal prognosis and was a significant predictor of clinical ...
NICE draft guidance recommends finerenone for heart failure. Learn more about the proposed NHS recommendation.
The introduction of respiratory biologics shows greatest benefits in patients with severe and eosinophilic asthma.
NEW Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifiYing patients (NECESSITY) is a ...
Largest UK trial finds trauma-focused therapy significantly reduces PTSD symptoms in people with psychosis, with high ...
A record number of Black and South Asian UK women are checking their breasts regularly for signs of cancer. Read more.
New AAIC 2026 data show an Alzheimer's blood test can predict cognitive decline risk up to a decade before symptoms appear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results